After the Recent Decline, Pulse Biosciences, Inc. (NASDAQ:PLSE) Top Key Executive Robert Duggan's Holdings Have Lost 13% of Their Value

Key Insights Insiders appear to have a vested interest in Pulse Biosciences' growth, as seen by their sizeable ownership 68% of the company is held by a single shareholder (Robert Duggan) Using da

Simply Wall StApr 5 19:19

Pulse Biosciences to Sell Subscription Rights to Purchase up to 6M Units

Seeking AlphaApr 4 22:00

Pulse Biosciences Shares Fall After Q4 Results, Rights Issue Plans

Pulse Biosciences (PLSE) shares fell more than 13% in recent Monday trading following its Q4 results late last week and plans to raise funds through a rights issue. Late Thursday, the company reported

MT NewswiresApr 2 02:19

Precision Biosciences, Mesoblast, Pulse Biosciences Among Healthcare Movers

Seeking AlphaApr 1 22:00

Oxford Industries, PVH And 3 Stocks To Watch Heading Into Monday

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects PVH Corp. (NYSE:PVH) to report quarterly earn

BenzingaApr 1 15:33

12 Health Care Stocks Moving In Friday's After-Market Session

GainersQilian Intl Hldg Gr (NASDAQ:QLI) shares rose 63.8% to $1.04 during Friday's after-market session. The market value of their outstanding shares is at $37.1 million. Sunshine Biopharma (NASDAQ:SB

BenzingaMar 30 04:30